Glenmark Pharmaceuticals Limited
company is engaged in the development, manufacturing, and marketing of both generic and innovative pharmaceutical products.CIN: L24299MH1977PLC019982
we “Glenmark Pharmaceuticals Limited” is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. Established in 1977, Glenmark has grown to become a leading player in the global pharmaceutical industry. The company is engaged in the development, manufacturing, and marketing of both generic and innovative pharmaceutical products.
Products & Services
Glenmark Pharmaceuticals offers a diverse range of products across multiple therapeutic areas. Here are some of the key product categories:
- Dermatology: Medications for various skin conditions such as acne, eczema, psoriasis, and fungal infections.
- Respiratory: Inhalers, nasal sprays, and other respiratory medications for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.
- Oncology: Anticancer drugs for the treatment of various types of cancers.
- Cardiovascular: Medications for hypertension, dyslipidemia, and cardiovascular diseases.
- Gastrointestinal: Drugs for the management of gastrointestinal disorders including acid reflux, ulcers, and inflammatory bowel disease.
- Central Nervous System: Treatments for neurological and psychiatric disorders like epilepsy, depression, and schizophrenia.
- Diabetes: Medications for the management of diabetes and related complications.
- Pain Management: Analgesics and pain relievers for acute and chronic pain conditions.
Frequently Asked Questions
Glenmark Pharmaceuticals maintains strict quality standards and has obtained certifications such as ISO 9001, ISO 14001, and ISO 27001. The company complies with Good Manufacturing Practices (GMP) and other regulatory guidelines in the countries where it operates.
Yes, Glenmark Pharmaceuticals has ventured into the development and manufacturing of biosimilars, which are similar versions of biologic drugs. These biosimilars are used to treat conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders.
Yes, Glenmark Pharmaceuticals has a strong global presence. It operates in more than 80 countries, with subsidiaries, representative offices, and manufacturing facilities worldwide. The company exports its products to various markets across Asia, Europe, Africa, and the Americas.
Yes, Glenmark Pharmaceuticals has a dedicated research and development division focused on discovering and developing innovative medicines. The company invests in cutting-edge research to address unmet medical needs and improve patient care.
Glenmark Pharmaceuticals has manufacturing facilities in multiple locations, including India, the United States, Switzerland, Brazil, and Argentina. These facilities adhere to strict quality standards and comply with regulatory guidelines.
